| BSI (n = 21) | non-BSI (n = 16) | P valued |
---|---|---|---|
Age at diagnosis (year)a | 39.8 ± 15.8 | 41.6 ± 18.9 | 0.746 |
Gender (M/F) | M 15 F 6 | M 10 F 6 | 0.726 |
Primary disease | – | ||
 AML | 10 | 2 | |
 ALL | 2 | 3 | |
 CMML | – | 1 | |
 MDS | 2 | 2 | |
 Lymphoma | 4 | – | |
 MM | 1 | 6 | |
 AA | 1 | 1 | |
 POEMS syndrome | 1 | – | |
 PNH | – | 1 | |
Types of HSCT | allo-HSCT 19 auto-HSCT 2 | allo-HSCT 10 auto-HSCT 6 | 0.055 |
Liver function | |||
 ALT (U/L)a | 70.4, 78.4 | 19.3, 11.5 | 0.001 |
 AST (U/L)a | 40.9, 38.7 | 19.0, 9.8 | 0.057 |
 GGT (U/L)a | 144.4, 151.9 | 42.1, 40.8 | < 0.001 |
Total bilirubin (µmol/L)a | 22.2, 28.6 | 12.2, 5.2 | 0.058 |
Direct bilirubin (µmol/L)a | 13.24, 22.8 | 4.8, 2.3 | 0.003 |
BSI related pathogensb | – | ||
Coagulase-Negative Staphylococcusc | 4 | – | |
Enterococcus faecium | 1 | – | |
Streptococcus spp. | 2 | – | |
Enterobacter cloacae | 2 | – | |
Escherichia coli | 5 | – | |
Klebsiella pneumoniae | 1 | – | |
Pseudomonas aeruginosa | 6 | – | |
Corynebacterium jeikeium | 1 | – |